Logo - International Journal of Pharmaceutical Compounding

Levorphanol for the Treatment of Severe Chronic Pain

Author(s):  McNulty Jack P

Issue:  May/Jun 2007 - Pain Management
View All Articles in Issue

Abstract:  The search for an effective and affordable treatment for severe chronic pain, particularly neuropathic pain, has been elusive. The reluctance of many physicians to prescribe strong opioids for pain when other modalities have failed has resulted in the undertreatment of many patients. Levorphanol is 1 of 2 opioids that block N-methyl-Daspartate receptors. In this article, the mechanism of N-methyl-D-aspartate receptor activation is described, the efficacy of levorphanol in the treatment of severe chronic pain is examined, and the properties and clinical applications of that agent are reviewed. Other N-methyl-D-aspartate receptor antagonists are commented upon, and the outcome of treatment with levorphanol in chronic-pain patients is described in detail.

Related Keywords: Jack P. McNulty, MD, FACP, FAAHPM, levorphanol, N-methyl-D-aspartate receptor antagonist, NMDA blocker, pain control, pain management, analgesia, analgesics, neuropathic pain, neuralgia, neuropathy, drug interactions, dextromethorphan, ketamine, amantadine, methadone, memantine, opioid conversion

Related Categories: FORMULATIONS, PAIN MANAGEMENT, CASE REPORTS, NEUROLOGY

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=2611

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products